Ledger.Open graph →
SEC Form D · filed March 15, 2021

U1 Bio, Inc

Offering
$650K
Sold
$450K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

David Nelles · San Francisco, CAExec · DirectorKonstantinos Charizanis · San Francisco, CAExec · DirectorEnda K. Fahy · Grand Duchy of Luxembourg, LuxembourgExec · DirectorCharles Shao · New York, NYExec · DirectorWilliam J. Geary · Boston, MAExec · DirectorRobert Welge, Iii · Winnetka, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗